VALIANT LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Valiant Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-3.95₹ -2.67
As on Jan 12, 2026, 4:01 PM IST
Valiant Laboratories Price Performance
Today's LowToday's High
₹64.36₹68.35
₹65.00
52 Weeks' Low52 Weeks' High
₹63.50₹113.88
₹65.00
Open Price
₹66.99
Prev. Close
₹67.67
Volume
1,515
Over the last 5 years, the share price of Valiant Laboratories has declined 16.16% CAGR. Over the past year, the corresponding return has been -35.84%.
Valiant Laboratories’s current P/E of 69.67x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Valiant Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Valiant Laboratories | -11.56 | -2.01 | -22.81 | -37.92 | -30.94 | -25.45 | -16.16 |
| Sun Pharmaceutical Industries | -1.46 | -3.50 | 3.95 | 3.11 | -0.67 | 19.69 | 22.81 |
| Divi's Laboratories | -2.29 | 2.29 | -0.95 | -4.29 | 13.26 | 22.83 | 11.17 |
| Torrent Pharmaceuticals | 0.29 | 4.43 | 12.17 | 15.88 | 21.90 | 36.14 | 22.58 |
| Cipla | -4.20 | -2.73 | -6.26 | -1.25 | 1.89 | 10.76 | 11.35 |
| Dr. Reddy's Laboratories | -3.24 | -5.09 | -3.70 | -2.85 | -8.91 | 12.32 | 2.33 |
| Lupin | 1.76 | 4.77 | 11.14 | 13.77 | 1.66 | 42.37 | 15.28 |
| Mankind Pharma | -0.87 | 3.71 | -8.99 | -17.68 | -14.21 | 15.99 | 9.31 |
| Zydus Lifesciences | -3.68 | -2.63 | -9.72 | -7.38 | -7.93 | 25.16 | 12.70 |
| Alkem Laboratories | 3.85 | 4.52 | 6.76 | 21.26 | 12.23 | 23.97 | 13.68 |
| Aurobindo Pharma | -4.89 | -1.19 | 3.05 | 2.87 | 0.83 | 37.57 | 3.96 |
| Abbott India | -0.06 | 1.86 | -5.16 | -17.37 | -0.47 | 8.98 | 12.89 |
| Glenmark Pharmaceuticals | -2.82 | 1.54 | 5.49 | -9.12 | 34.61 | 67.31 | 30.97 |
| Laurus Labs | -6.78 | 3.57 | 18.76 | 26.21 | 86.15 | 40.05 | 24.33 |
| Biocon | -3.69 | -5.04 | 6.17 | -2.20 | 1.66 | 12.87 | -4.67 |
| GlaxoSmithKline Pharmaceuticals | -3.37 | -6.85 | -12.81 | -24.74 | 14.76 | 22.42 | 8.90 |
| Ipca Laboratories | 5.36 | 7.39 | 17.02 | 6.23 | -2.01 | 21.13 | 7.94 |
| Anthem Biosciences | -3.86 | -11.65 | -21.33 | -15.47 | -15.47 | -5.45 | -3.30 |
| Ajanta Pharma | -3.97 | 3.60 | 13.08 | 3.22 | -1.79 | 32.73 | 17.78 |
| J B Chemicals & Pharmaceuticals | -0.20 | 4.57 | 12.73 | 14.28 | 5.42 | 25.12 | 29.19 |
Over the last one year, Valiant Laboratories has declined 30.94% compared to peers like Sun Pharmaceutical Industries (-0.67%), Divi's Laboratories (13.26%), Torrent Pharmaceuticals (21.90%). From a 5 year perspective, Valiant Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (22.81%) and Divi's Laboratories (11.17%).
Valiant Laboratories Financials
Valiant Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 71.06 | 68.44 |
| 10 | 71 | 69.53 |
| 20 | 70 | 70.04 |
| 50 | 72.83 | 72.93 |
| 100 | 79.38 | 78.19 |
| 200 | 87.25 | 86.03 |
Valiant Laboratories Share Holding Pattern
In the latest quarter, Valiant Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding fell to 0.02%, and public shareholding moved up to 25.05% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Valiant Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 07, 2026, 4:50 PM IST | Valiant Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 26, 2025, 9:59 PM IST | Valiant Laboratories - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulatio |
| Nov 11, 2025, 11:37 PM IST | Valiant Laboratories - Board Comments On The Communication Received From The Stock Exchanges |
| Nov 11, 2025, 10:43 PM IST | Valiant Laboratories - Announcement under Regulation 30 (LODR)-Monitoring Agency Report |
| Nov 11, 2025, 10:33 PM IST | Valiant Laboratories - Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 |
About Valiant Laboratories
Valiant Laboratories Ltd. is a Public Limited Listed company incorporated on 06/08/2021 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH2021PLC365904 and registration number is 365904. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 133.36 Cr. and Equity Capital is Rs. 43.45 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address104, Udyog Kshetra, Mulund Goregaon Link Road, Mumbai Maharashtra 400080
- Contact
Management
- Mr. Santosh S VoraManaging Director
- Mr. Paresh S ShahExecutive Director & CFO
- Mr. Shantilal S VoraNon Executive Director
- Mr. Sandeep N GuptaNon Executive Director
- Mrs. Sonal A ViraInd. Non-Executive Director
- Mr. Mulesh M SavlaInd. Non-Executive Director
- Mr. Ashok ChhedaInd. Non-Executive Director
FAQs on Valiant Laboratories Share Price
What is the share price of Valiant Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Valiant Laboratories is ₹65.00 as on Jan 12, 2026.
What kind of stock is Valiant Laboratories?
The Valiant Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Valiant Laboratories?
The market cap of Valiant Laboratories is ₹353.03 Cr as on Jan 12, 2026.
What are today's High and Low prices of Valiant Laboratories?
Today’s highest and lowest price of Valiant Laboratories are ₹68.35 and ₹64.36.
What are the 52 Week High and 52 Week Low of Valiant Laboratories?
The 52-week high/low is the highest and lowest price at which Valiant Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Valiant Laboratories is ₹113.88 and 52-week low of Valiant Laboratories is ₹63.50 as on Jan 12, 2026.
How has the Valiant Laboratories performed historically in terms of returns?
The Valiant Laboratories has shown returns of -3.95% over the past day, -2.56% for the past month, -25.03% over 3 months, -35.84% over 1 year, -25.45% across 3 years, and -16.16% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Valiant Laboratories?
P/E ratio of and PB ratio of Valiant Laboratories are 69.67 and 1.11 on Jan 12, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse